In this study, we report a case of multidrug-resistant influenza A(H3N2) virus isolated from an immunosuppressed patient with prolonged viral shedding. We also describe the genetic characterization of the haemagglutinin, neuraminidase and M2 influenza genes. The virus contained the substitutions E119V in neuraminidase and V27A in M2, which produce resistance to oseltamivir and adamantanes, respectively. This is the first report of this dual mutation pattern in multidrug-resistant influenza A(H3N2) virus.
References
1.
BazM., AbedY., McDonaldJ., BoivinG.Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.Clin Infect Dis2006; 43: 1555–1561.
2.
RochaE., CoxN.J., BlackR.A., HarmonM.W., HarrisonC.J., KendalA. P.. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child.J Virol1991; 65: 2340–2350.
3.
Centers for Disease Control and Prevention.Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients – Seattle, Washington, 2009.MMWR Morb Mortal Wkly Rep2009; 58: 893–896.
4.
GooskensJ., JongesM., ClaasE.C., MeijerA., KroesA.C.Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.J Infect Dis2009; 199: 1435–1441.
5.
IsonM.G., GubarevaL.V., AtmarR.L., TreanorJ., HaydenF.G.Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.J Infect Dis2006; 193: 760–764.
6.
WeinstockD.M., GubarevaL.V., ZuccottiG.Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.N Engl J Med2003; 348: 867–868.
7.
CoirasM.T., AguilarJ.C., GarciaM.L., CasasI., Perez-BrenaP.Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays.J Med Virol2004; 72: 484–495.
8.
Lopez-HuertasM.R., CasasI., Acosta-HerreraB., GarciaM.L., CoirasM.T., Perez-BrenaP.Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates.J Virol Methods2005; 129: 1–7.
9.
Ruiz-CarrascosoG., CasasI., PozoF., Pérez-GonzálezC., ReinaJ., Pérez-BreñaP.Development and implementation of influenza A virus subtyping and detection of genotypic resistance to neuraminidase inhibitors.J Med Virol2010; 82: 843–853.
10.
HolsingerL.J., ShaughnessyM.A., MickoA., PintoL.H., LambR.A.Analysis of the posttranslational modifications of the influenza virus M2 protein.J Virol1995; 69: 1219–1225.
11.
MatrosovichM., GaoP., KawaokaY.Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.J Virol1998; 72: 6373–6380.
12.
BoivinG., GoyetteN., BernatchezH.Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient.Clin Infect Dis2002; 34: E23–E25.
13.
GubarevaL.V.Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.Virus Res2004; 103: 199–203.
14.
SaitoR., SakaiT., SatoI.Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2.J Clin Microbiol2003; 41: 2164–2165.
15.
DeydeV.M., XuX., BrightR.A.Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.J Infect Dis2007; 196: 249–257.
16.
GranthamM.L., WuW.H., LalimeE.N., LorenzoM.E., KleinS.L., PekoszA.Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence.J Virol2009; 83: 8655–8661.
